94 related articles for article (PubMed ID: 24573400)
1. Novel cancer-testis antigen expression on glioma cell lines derived from high-grade glioma patients.
Akiyama Y; Komiyama M; Miyata H; Yagoto M; Ashizawa T; Iizuka A; Oshita C; Kume A; Nogami M; Ito I; Watanabe R; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Yamaguchi K
Oncol Rep; 2014 Apr; 31(4):1683-90. PubMed ID: 24573400
[TBL] [Abstract][Full Text] [Related]
2. Cancer-testis and melanocyte-differentiation antigen expression in malignant glioma and meningioma.
Syed ON; Mandigo CE; Killory BD; Canoll P; Bruce JN
J Clin Neurosci; 2012 Jul; 19(7):1016-21. PubMed ID: 22534618
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
4. HER-2, gp100, and MAGE-1 are expressed in human glioblastoma and recognized by cytotoxic T cells.
Liu G; Ying H; Zeng G; Wheeler CJ; Black KL; Yu JS
Cancer Res; 2004 Jul; 64(14):4980-6. PubMed ID: 15256472
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B
J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898
[TBL] [Abstract][Full Text] [Related]
6. The prostate stem cell antigen represents a novel glioma-associated antigen.
Geiger KD; Hendruschk S; Rieber EP; Morgenroth A; Weigle B; Juratli T; Senner V; Schackert G; Temme A
Oncol Rep; 2011 Jul; 26(1):13-21. PubMed ID: 21503583
[TBL] [Abstract][Full Text] [Related]
7. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
[TBL] [Abstract][Full Text] [Related]
8. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
[TBL] [Abstract][Full Text] [Related]
9. DDX3X Biomarker Correlates with Poor Survival in Human Gliomas.
Hueng DY; Tsai WC; Chiou HY; Feng SW; Lin C; Li YF; Huang LC; Lin MH
Int J Mol Sci; 2015 Jul; 16(7):15578-91. PubMed ID: 26184164
[TBL] [Abstract][Full Text] [Related]
10. Cancer-testis antigens expressed in osteosarcoma identified by gene microarray correlate with a poor patient prognosis.
Zou C; Shen J; Tang Q; Yang Z; Yin J; Li Z; Xie X; Huang G; Lev D; Wang J
Cancer; 2012 Apr; 118(7):1845-55. PubMed ID: 22009167
[TBL] [Abstract][Full Text] [Related]
11. Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.
Prosniak M; Harshyne LA; Andrews DW; Kenyon LC; Bedelbaeva K; Apanasovich TV; Heber-Katz E; Curtis MT; Cotzia P; Hooper DC
Clin Cancer Res; 2013 Jul; 19(14):3776-86. PubMed ID: 23741072
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of PCDH9 predicts prognosis for patients with glioma.
Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma.
Strojnik T; Smigoc T; Lah TT
Anticancer Res; 2014 Jan; 34(1):339-47. PubMed ID: 24403485
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.
Chi DD; Merchant RE; Rand R; Conrad AJ; Garrison D; Turner R; Morton DL; Hoon DS
Am J Pathol; 1997 Jun; 150(6):2143-52. PubMed ID: 9176405
[TBL] [Abstract][Full Text] [Related]
16. WT1 expression increases with malignancy and indicates unfavourable outcome in astrocytoma.
Rauscher J; Beschorner R; Gierke M; Bisdas S; Braun C; Ebner FH; Schittenhelm J
J Clin Pathol; 2014 Jul; 67(7):556-61. PubMed ID: 24607494
[TBL] [Abstract][Full Text] [Related]
17. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501
[TBL] [Abstract][Full Text] [Related]
18. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
20. Forkhead-box A1 transcription factor is a novel adverse prognosis marker in human glioma.
Wang L; Qin H; Li L; Feng F; Ji P; Zhang J; Li G; Zhao Z; Gao G
J Clin Neurosci; 2013 May; 20(5):654-8. PubMed ID: 23510544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]